The rapid adoption of GLP-1 receptor agonists for diabetes and weight loss has raised concerns in the endoscopy suite due to potential risks like delayed gastric emptying and aspiration during procedures requiring sedation. Anesthesiologists have called for holding GLP-1s a week prior to elective procedures, causing tensions with gastroenterologists who argue the evidence is insufficient. Both sides agree more research is needed to guide best practices, and new guidelines are being developed to address these concerns while minimizing unnecessary cancellations.
GIs clash with GLP-1 restrictions for endoscopy, but ‘anesthesiologists have final say’ (Healio)
0